(Q48029839)

7 February 2018

title

Validation of antibacterial mechanism of action using regulated antisense RNA expression in Staphylococcus aureus. (English)

1 reference

7 February 2018

main subject

Staphylococcus aureus

1 reference

Yinduo Ji

1

1 reference

7 February 2018

Dezhong Yin

2

1 reference

7 February 2018

Brian Fox

3

1 reference

7 February 2018

David J Holmes

4

1 reference

7 February 2018

David Payne

5

1 reference

7 February 2018

Martin Rosenberg

6

1 reference

7 February 2018

publication date

1 February 2004

1 reference

7 February 2018

FEMS Microbiology Letters

published in

1 reference

7 February 2018

volume

231

1 reference

7 February 2018

page(s)

177-184

1 reference

7 February 2018

issue

2

1 reference

7 February 2018

Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900931-5

The millennium bugs--the need for and development of new antibacterials

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900931-5

7 January 2021

'Superbug' hurdles key drug barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900931-5

7 January 2021

Systematic identification of essential genes by in vitro mariner mutagenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900931-5

7 January 2021

A genome-based approach for the identification of essential bacterial genes.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900931-5

7 January 2021

Regulated expression of heterologous genes in Bacillus subtilis using the Tn10 encoded tet regulatory elements

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900931-5

7 January 2021

Characterization of a novel fucose-regulated promoter (PfcsK) suitable for gene essentiality and antibacterial mode-of-action studies in Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900931-5

7 January 2021

Regulated gene expression in Staphylococcus aureus for identifying conditional lethal phenotypes and antibiotic mode of action

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900931-5

7 January 2021

Genome-wide expression patterns in Saccharomyces cerevisiae: comparison of drug treatments and genetic alterations affecting biosynthesis of ergosterol

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900931-5

7 January 2021

Gene expression changes triggered by exposure of Haemophilus influenzae to novobiocin or ciprofloxacin: combined transcription and translation analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900931-5

7 January 2021

Analysis of topoisomerase function in bacterial replication fork movement: use of DNA microarrays

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900931-5

7 January 2021

Proteomic approach to understanding antibiotic action

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900931-5

7 January 2021

An antisense-based functional genomics approach for identification of genes critical for growth of Candida albicans

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900931-5

7 January 2021

Antisense inhibition of gene expression in bacteria by PNA targeted to mRNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900931-5

7 January 2021

Regulated antisense RNA eliminates alpha-toxin virulence in Staphylococcus aureus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900931-5

7 January 2021

Identification of critical staphylococcal genes using conditional phenotypes generated by antisense RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900931-5

7 January 2021

A genome-wide strategy for the identification of essential genes in Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900931-5

7 January 2021

Enoyl-acyl carrier protein reductase (fabI) plays a determinant role in completing cycles of fatty acid elongation in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900931-5

7 January 2021

Bacterial fatty-acid biosynthesis: a genomics-driven target for antibacterial drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900931-5

7 January 2021

Discovery of a novel and potent class of FabI-directed antibacterial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900931-5

7 January 2021

Identification of essential genes in Staphylococcus aureus using inducible antisense RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900931-5

7 January 2021

The effect of loop size in antisense and target RNAs on the efficiency of antisense RNA control

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900931-5

7 January 2021

Effects of RNA secondary structure on cellular antisense activity

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900931-5

7 January 2021

Inhibitors of bacterial enoyl acyl carrier protein reductase (FabI): 2,9-disubstituted 1,2,3,4-tetrahydropyrido[3,4-b]indoles as potential antibacterial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900931-5

7 January 2021

1,4-Disubstituted imidazoles are potential antibacterial agents functioning as inhibitors of enoyl acyl carrier protein reductase (FabI)

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900931-5

7 January 2021

Discovery of aminopyridine-based inhibitors of bacterial enoyl-ACP reductase (FabI)

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900931-5

7 January 2021

Indole Naphthyridinones as Inhibitors of Bacterial Enoyl-ACP Reductases FabI and FabK

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1097%2803%2900931-5

7 January 2021

10.1016/S0378-1097(03)00931-5

Identifiers

DOI

1 reference

7 February 2018

release_pfpkh2lhuvfv5gd6qmcu63glbe

Fatcat ID

0 references

PubMed ID

14987762

1 reference

7 February 2018